Penumbra, Inc. (NYSE: PEN), the world's leading thrombectomy company, announced new data that demonstrate patients with intermediate-risk pulmonary embolism (PE) treated with Penumbra's computer ...
Hosted on MSN11mon
Penumbra (PEN) Gains From Innovation, Mounting Costs AilCombined with Flash and Bolt 7, Penumbra expects its CAVT portfolio to drive both market share and market growth in Deep vein thrombosis, Pulmonary embolism and arterial. In terms of global ...
WBAL TV Baltimore on MSN2d
Mother shares story of survival after pulmonary embolism during childbirthA mom who takes nothing for granted is sharing her story after almost dying from a pulmonary embolism during childbirth.
News Medical on MSN13d
Evaluating the safety and efficacy of Tendvia mechanical thrombectomy for acute pulmonary embolismAnnouncing a new article publication for Cardiovascular Innovations and Applications journal. Mechanical thrombectomy is effective and safe for treating pulmonary embolism (PE).
Penumbra, Inc. (NYSE: PEN), the world's leading thrombectomy company, announced new data that demonstrate patients with intermediate-risk pulmonary embolism (PE) treated with Penumbra's computer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback